Relationship between 2,4,5-trichlorophenoxyacetate and the renal organic base transport system.
D015085:2,4,5-Trichlorophenoxyacetic Acid / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001692:Biological Transport / Q000187:drug effects; D066298:In Vitro Techniques; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D013757:Tetraethylammonium Compounds / Q000378:metabolism; D013997:Time Factors; D010130:p-Aminohippuric Acid / Q000378:metabolism
D000963:Antimetabolites; D013757:Tetraethylammonium Compounds; D009536:Niacinamide; D015085:2,4,5-Trichlorophenoxyacetic Acid; D010130:p-Aminohippuric Acid